Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ABBOTT LABORATORIES et al V. IMPAX LABORATORIES, INC.
Case Number:
2:10-cv-01322
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 20, 2011
Abbott, Fournier Settle With Impax Over Generic Trilipix
Impax Laboratories Inc. on Thursday settled a patent infringement suit brought by Abbott Laboratories and Fournier Laboratories Ireland Ltd. in New Jersey over the generic-drug maker's efforts to market a version of cholesterol drug Trilipix.
-
March 16, 2010
Trilipix ANDA Spurs Abbott, Fournier To Sue Impax
Abbott Laboratories and Fournier Laboratories Ireland Ltd. have fired off a patent infringement complaint against Impax Laboratories Inc., claiming that the generic-drug maker infringed their patent by applying to market its own version of the companies' cholesterol drug.